XtalPi announced on 23 June 2025 a term sheet with DoveTree LLC under which it would discover and develop drug candidates for targets selected by DoveTree and receive initial payments of US$51 million and US$49 million after signing a definitive agreement, subject to further negotiation.
One recorded claim. The claim panel gives its qualification, the source passages with their place in each source, and how it was checked.
What it connects
XtalPi / 晶泰科技 → announced a partnership with → DoveTree
Where it appears
No collection page holds this claim. It is listed with its records in the explorer.